Cardioprotection by ICRF187 against high dose anthracycline toxicity in children with malignant disease.

OBJECTIVE--A pilot study to assess the efficacy of ICRF187 as a protective agent against the cardiotoxic effects of anthracycline drugs used to treat childhood malignancies. DESIGN--A study of cardiac function in children treated receiving ICRF187 ((s)-(+)-1,2 bis (3,5-dioxopiperazenyl) propane) in...

Full description

Saved in:
Bibliographic Details
Main Authors: Bu'Lock, F A, Gabriel, H M, Oakhill, A, Mott, M G, Martin, R P
Format: Artigo
Language:Inglês
Published: 1993
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC1025283/
https://ncbi.nlm.nih.gov/pubmed/8038032
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items